InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Billen Daniel. Director active across 1 company, notably Aurinia Pharmaceuticals Inc.. In total, 4 filings have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €76k. Activity tracked since 19 May 2023. The latest transaction was filed on 21 May 2024 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Billen Daniel is a Director at Aurinia Pharmaceuticals Inc. (XNAS). He has 4 filings in total, and in the 4 recent filings we hold, the transactions are sales, with 76388 euros of selling between 2023-05-23 and 2024-05-22.